Richard P. Harbottle

3.4k citations

71 papers · 2.3k indexed · h-index 28

Co-authors: Charles Coutelle Andrew D. Miller Stephen L. Hart Suet Ping Wong Orestis Argyros Andrew M. Knight RG Cooper Suet‐Ping Wong
Topics: RNA Interference and Gene Delivery (33 papers)Virus-based gene therapy research (31 papers)CRISPR and Genetic Engineering (16 papers)
Cited by: Genetics Molecular Biology Immunology and Allergy
Journals: Journal of Biological Chemistry Angewandte Chemie International Edition Nature Biotechnology
Partner nations: United Kingdom Germany United States

In The Last Decade

Richard P. Harbottle

66 papers receiving 2.2k citations

Peers

Countries citing papers authored by Richard P. Harbottle

Since Specialization

Citations

This map shows the geographic impact of Richard P. Harbottle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Harbottle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Harbottle more than expected).

Fields of papers citing papers by Richard P. Harbottle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Harbottle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Harbottle. The network helps show where Richard P. Harbottle may publish in the future.

Co-authorship network of co-authors of Richard P. Harbottle

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. Harbottle. A scholar is included among the top collaborators of Richard P. Harbottle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. Harbottle. Richard P. Harbottle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector 2025 ·Stem Cell Research & Therapy ·(unknown),(unknown),Matthew W. Urban,Adam Hartley,(unknown),Marijke Koedam,Thierry van den Bosch,Marian C. Clahsen‐van Groningen,Joost Gribnau,Jaap Mulder,Marlies E. J. Reinders,Carla C. Baan,Bram C. J. van der Eerden,Richard P. Harbottle,Martin J. Hoogduijn	0
2	Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice 2023 ·Pathogens ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Matthias Bozza,Karin Hoppe‐Seyler,Mathias Heikenwälder,Richard P. Harbottle,Carine Michiels,Angelika B. Riemer	0
3	P06.05.A INTRACEREBROVENTRICULAR TCR-TRANSGENIC T CELL THERAPY TO TREAT GLIOBLASTOMA (INVENT4GB) 2023 ·Neuro-Oncology ·Lukas Bunse,(unknown),(unknown),Khwab Sanghvi,(unknown),Richard P. Harbottle,Stefan B. Eichmüller,Axel Benner,(unknown),Isabel Poschke,Patrick Schmidt,Joachim P. Steinbach,Peter Vajkoczy,Lars Bullinger,Ghazaleh Tabatabai,(unknown),Halvard Bönig,Wolfgang Wick,Michael Platten	1
4	Successful large gene augmentation of USH2A with non-viral episomal vectors 2023 ·Molecular Therapy ·Maria Toms,(unknown),Patrick Almeida,Richard P. Harbottle,Mariya Moosajee	14
5	Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia 2023 ·International Journal of Molecular Sciences ·(unknown),Maria Toms,Patrick Almeida,Richard P. Harbottle,Mariya Moosajee	3
6	NLGN4X TCR transgenic T cells to treat gliomas 2023 ·Neuro-Oncology ·(unknown),Michael Kilian,(unknown),(unknown),Dirk C. Hoffmann,(unknown),P. Koopmann,Khwab Sanghvi,(unknown),Stefanie Jung,Kristine Jähne,Bryan W. Day,(unknown),Miriam Ratliff,Richard P. Harbottle,Edward W. Green,Rainer Will,Wolfgang Wick,Michael Platten,Lukas Bunse	9
7	An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny 2021 ·Stem Cell Reports ·(unknown),Manuela Urban,Matthias Bozza,(unknown),(unknown),(unknown),Sina Stäble,Franciscus van der Hoeven,Karin Müller‐Decker,Tristan R. McKay,Michael D. Milsom,Richard P. Harbottle	19
8	Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models 2020 ·Molecular Therapy — Methods & Clinical Development ·Matthias Bozza,Edward W. Green,Elisa Espinet,(unknown),Corinna Klein,Vanessa Vogel,Rienk Offringa,James A. Williams,Martin R. Sprick,Richard P. Harbottle	23
9	Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice 2018 ·PLoS Pathogens ·Daniele Viarisio,Karin Müller‐Decker,Rosita Accardi,Alexis Robitaille,Matthias Dürst,Katrin Beer,Lars Jansen,Christa Flechtenmacher,Matthias Bozza,Richard P. Harbottle,Catherine Voegele,Maude Ardin,Jiří Zavadil,Sandra Caldeira,Lutz Gissmann,Massimo Tommasino	83
10	Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model 2016 ·Journal of Ocular Pharmacology and Therapeutics ·Mariya Moosajee,Dhani Tracey‐White,Richard P. Harbottle,(unknown)	0
11	Sustained Expression from DNA Vectors 2014 ·Advances in genetics ·Suet Ping Wong,Orestis Argyros,Richard P. Harbottle	22
12	Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors 2013 ·Molecular Therapy — Nucleic Acids ·Suet‐Ping Wong,Richard P. Harbottle	7
13	Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice 2013 ·Molecular Therapy — Nucleic Acids ·Anne Dallas,Heini Ilves,Joshua Shorenstein,Adam D. Judge,Ryan Spitler,Christopher H. Contag,Suet Ping Wong,Richard P. Harbottle,Ian MacLachlan,Brian H. Johnston	14
14	Persistent Expression of Non-Viral S/MAR Vectors in the RPE for Choroideremia Gene Therapy 2010 ·Investigative Ophthalmology & Visual Science ·(unknown),Mariya Moosajee,Suet Ping Wong,Dhani Tracey‐White,Tanya Tolmachova,Richard P. Harbottle,Miguel C. Seabra	2
15	Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage 2010 ·Gene Therapy ·Suet Ping Wong,Orestis Argyros,Charles Coutelle,Richard P. Harbottle	33
16	LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives 2010 ·International Archives of Medicine ·Faisal A. Al-Allaf,Charles Coutelle,Simon N. Waddington,Anna L. David,Richard P. Harbottle,Michael Themis	39
17	Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector 2008 ·Gene Therapy ·Orestis Argyros,Suet Ping Wong,Marcello Niceta,Simon N. Waddington,Steven J. Howe,Charles Coutelle,Andrew D. Miller,Richard P. Harbottle	73
18	Nuclear Localisation Sequence Templated Nonviral Gene Delivery Vectors: Investigation of Intracellular Trafficking Events of LMD and LD Vector Systems 2003 ·ChemBioChem ·Michael Keller,Richard P. Harbottle,Éric Pérouzel,Morvane Colin,Syed Imran Ali Shah,Rahimin Affandi Abdul Rahim,Laurence Vaysse,(unknown),S. Moritz,Christiane Brahimi‐Horn,Charles Coutelle,Andrew D. Miller	59
19	An RGD–Oligolysine Peptide: A Prototype Construct for Integrin-Mediated Gene Delivery 1998 ·Human Gene Therapy ·Richard P. Harbottle,Robert G. Cooper,Stephen L. Hart,Axel Ladhoff,Tristan R. McKay,Andrew M. Knight,Ernst Wagner,Andrew D. Miller,Charles Coutelle	149
20	A novel peptide, PLAEIDGIELTY, for the targeting of α₉β₁‐integrins 1998 ·FEBS Letters ·Holm Schneider,Richard P. Harbottle,Yasuyuki Yokosaki,Jan Kunde,Dean Sheppard,Charles Coutelle	23

About Richard P. Harbottle

Richard P. Harbottle is a scholar working on Genetics, Molecular Biology and Immunology and Allergy, having authored 71 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (33 papers), Virus-based gene therapy research (31 papers) and CRISPR and Genetic Engineering (16 papers). The work is most often cited by research in Genetics (988 citations), Molecular Biology (1.7k citations) and Immunology and Allergy (76 citations). Richard P. Harbottle has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Charles Coutelle, Andrew D. Miller, Stephen L. Hart, Suet Ping Wong, Orestis Argyros, Andrew M. Knight, RG Cooper, Suet‐Ping Wong, Simon N. Waddington and Matthias Bozza. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact